Results 211 to 220 of about 7,643,641 (304)

Expanding Clinical and Variant Spectrum of CBX1-Related Syndrome: Report of Three Novel Cases. [PDF]

Clin Genet
Carrillo G, Fujino S, Higgs H, Kabahizi A, Le R, Rabin R, Pappas J, Crunk A, Ranguin K, Mortreux J, AURAGEN Consortium, Lackmy M, Gadia CA, Chau MHK, Rosenfeld JA, Luo X, Izumi K.   +16 more
europepmc   +1 more source

Tumour‐proximal deep serum proteomics identifies biomarkers associated with ovarian cancer

Molecular Oncology, EarlyView.
New biomarkers are needed for early ovarian cancer detection. Ovarian (tumour‐proximal) and peripheral vein serum from healthy women and patients with benign or malignant tumours underwent nanoparticle‐enriched deep proteomics. Ovarian serum yielded more protein identifications and revealed tumour‐reflective signatures.
Darren Lau, Daniel Pincher, Clifford Young, Nicholas Chappell, Noor A. Lokman, Parul Mittal, Leigh Donnellan, Martin K. Oehler, Doug A. Brooks, Peter Hoffmann   +9 more
wiley   +1 more source

Professional bodies: how best to promote and support individuals working in human genetics and genomics. [PDF]

J Hum Genet
Newman WG.
europepmc   +1 more source

Attitudes of cancer patients toward ctDNA‐based liquid biopsy for follow‐up

Molecular Oncology, EarlyView.
This mixed‐methods study explored cancer patients' experiences, knowledge, and preferences regarding ctDNA‐based liquid biopsy for follow‐up. Awareness of ctDNA was low and recall of previous liquid biopsy was imperfect, yet acceptance was high.
Siddharth Chhajlani, Laura Mariën, Caro De Weerdt, Sanne Wouters, Laure‐Anne Teuwen, Hans Prenen, Katleen Janssens, Timon Vandamme   +7 more
wiley   +1 more source

Selection of Genetic Conditions for Multi-State Genomic Newborn Screening in BRIDGES-NBS. [PDF]

Genet Med
Gold NB, Johnson BA, Somanchi H, Minten T, Coury SA, Zawatsky CB, Begtrup A, Butler E, Langley KG, Zimmerman R, McLaughlin HM, Ellefson T, Kern A, Rehm HL, Bick D, Brenner SE, Kasperaviciute D, Abraham RS, Aksentijevich I, Babinski M, Billington CJ, Butte MJ, Canna SW, Caron M, Chan YM, Chandrakasan S, Chiang SCC, Delmonte OM, Diller LR, Downie L, Fleischer J, Fulton A, Ganetzky RD, Gold J, Goldbach-Mansky R, Grunebaum E, Hale RC, Hamosh A, Hildebrandt F, Holtz AM, Jacobsen C, Kan MJ, Kitcharoensakkul M, Kodyte V, Kreienkamp RJ, Lennerz BS, Lin AE, Madduri AV, Majzoub JA, Marsh RA, Miller DT, Milner JD, Mitchell DM, Murray B, Notarangelo LD, Peng XP, Place EM, Platt CD, Plon SE, Plotkin SR, Powell CM, Puck JM, Roberts AE, Sankaran VG, Schwartz DM, Seroogy CM, Srinath S, Strong A, Sullivan KE, Tan W, Tarrant TK, Thiagarajah JR, Walker MA, Wassner AJ, Bolanos HZ, BRIDGES-NBS team, Gaviglio AM, Bonhomme N, Ojodu J, Singh S, Zarbalian G, Pereira S, Goldenberg AJ, Holm IA, Wasserstein MP, Green RC.   +85 more
europepmc   +1 more source

The impact of leukocyte‐associated RNA retention on platelet RNA‐based cancer detection

Molecular Oncology, EarlyView.
Platelets carry RNA signals that may help detect cancer, but platelet samples can also retain RNA from white blood cells. We found that this retained white blood cell signal did not significantly affect machine learning cancer classification, suggesting that the cancer‐related RNA signal in platelets is largely independent of leukocyte‐associated RNA ...
Michał Sieczczyński, Krzysztof Pastuszak, Anna Samelak‐Czajka, Zuzanna Cemka, Paulina Jackowiak, Tomasz Stefaniak, Sylwia Łapińska‐Szumczyk, Jacek Jassem, Anna J. Żaczek, Matthew T. Rondina, Myron G. Best, Sjors G. J. G. In 't Veld, Anna Supernat   +12 more
wiley   +1 more source

Correction: Mutational patterns in a large cohort of parathyroid carcinomas. [PDF]

J Endocrinol Invest
Pandya C, Uzilov AV, Costa-Guda J, Bellizzi J, Taik P, Moe AS, Strahl M, van der Tuin K, Stevenson M, Cavaco BM, Cetani F, Marcocci C, Karhu A, Arola J, Schalin-Jäntti C, Morreau H, Thakker RV, Schadt EE, Sebra R, Li SD, Chen R, Arnold A.   +21 more
europepmc   +1 more source

Vascular normalization confers an endothelial immune suppressive gene expression profile

Molecular Oncology, EarlyView.
We compare the immunoregulatory gene expression profiles of healthy endothelial cells or endothelial cells from tumors having a normalized endothelium (low leakage) with that of wild‐type tumors (high leakage) and observe that the wild‐type tumor endothelium exhibits immunostimulatory properties.
Liqun He, Michael Welsh
wiley   +1 more source

Reflections on the early days of the DNA damage response pathway in eukaryotes. [PDF]

Genetics
Elledge SJ.
europepmc   +1 more source

Overcoming platinum resistance by the disulfiram metabolite CuET in novel preclinical models of human carcinomas

Molecular Oncology, EarlyView.
Cisplatin‐resistant cancer cells survive DNA‐damaging platinum‐based treatment yet remain sensitive to CuET‐induced proteotoxic stress. The distinct mechanism of action allows CuET to overcome and eliminate cisplatin‐resistant tumour cells, unless highly expressed metallothioneins (MTs) interfere with CuET, thereby highlighting MT levels as candidate ...
Stefanos Arampatzis, Tereza Buchtová, Jirina Bartkova, Marie Lund Bay, Christoffer Lynge Halvorsen, Zuzana Machacova, Zdenek Skrott, Martin Mistrik, Ekaterina Dulina, Miguel Andujar‐Sanchez, Estrid Høgdall, Tine Henrichsen Schnack, Claus Høgdall, Berit Jul Mosgaard, Marie Boennelycke, Jacob Brink Laursen, Allan Jensen, Susanne K. Kjær, Tuula Kallunki, Robert Strauss, Jiri Bartek   +20 more
wiley   +1 more source